PE Ratio
10.26
₹14.10 -0.75 (-5.05%)
As on September 4, 2026
-23.58%
1 Y CAGR
20
CR
Market Cap
Company profile
Nidan Laboratories & Healthcare Ltd. is an India-based company operating in the healthcare sector, specializing in comprehensive diagnostic services. The company provides an extensive range of pathology services, including biochemistry, hematology, microbiology, cytogenetic, and molecular diagnostic tests. Additionally, it offers a broad spectrum of radiology services such as CT scans, MRI, X-rays, and ultrasounds, along with cardiology and neurology diagnostic services and various health and wellness packages. Nidan Laboratories & Healthcare employs a "one-stop" integrated diagnostic model, serving both retail and institutional clients primarily across Maharashtra, India, particularly within the Mumbai Metropolitan Region. Its operational framework utilizes a "Hub and Spoke" model, featuring a central processing laboratory supported by multiple collection centers and satellite labs, and it is actively expanding its presence into Tier-2 cities through a franchise network.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.019
Dividend Yield
0.00%
Sector PE
42.60
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹0.3KCAGR 5-Year
-3.67%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
